Glioblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we report on the expression of wild-type and L441P variants of human PO in a U87 glioblastoma human cell line in an attempt to assess their effect on glutamate metabolism.
|
29694413 |
2018 |
Gastrointestinal Carcinoid Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We used GCT derived cell lines of varying differentiation stages to analyze expression of HERVK and PRODH.
|
29963023 |
2018 |
Adult Glioblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we report on the expression of wild-type and L441P variants of human PO in a U87 glioblastoma human cell line in an attempt to assess their effect on glutamate metabolism.
|
29694413 |
2018 |
Childhood Glioblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we report on the expression of wild-type and L441P variants of human PO in a U87 glioblastoma human cell line in an attempt to assess their effect on glutamate metabolism.
|
29694413 |
2018 |
Glioblastoma Multiforme
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we report on the expression of wild-type and L441P variants of human PO in a U87 glioblastoma human cell line in an attempt to assess their effect on glutamate metabolism.
|
29694413 |
2018 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We generated a constitutively knocked-down PRODH/POX MCF-7 breast cancer cell line (MCF-7shPRODH/POX) as a model to analyze the functional consequences of impaired intracellular proline levels.
|
28942439 |
2017 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, we show that proline oxidase (PRODH1) is required for PDAC cell proliferation in vitro and in vivo.
|
28685754 |
2017 |
Necrotizing enterocolitis in fetus OR newborn
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our results showed that expressions of arginine synthesizing enzymes ALDH18A1, ASL, ASS1, CPS1, GLS, OAT and PRODH were significantly decreased in NEC compared with Surg-CTL or SIP tissues.
|
26895666 |
2016 |
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
In the TOF patients, we found four copy number gains affecting three genes, of which two are important regulators of heart development (NOTCH1, ISL1) and one is located in a region associated with cardiac malformations (PRODH at 22q11).
|
24400131 |
2014 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
PRODH maps to chromosome 22q11, a region conferring the highest known genetic risk of schizophrenia, and encodes proline oxidase, which catalyzes proline catabolism. l-Proline is a neuromodulator at glutamatergic synapses, and peripheral hyperprolinemia has been associated with decreased IQ, cognitive impairment, schizoaffective disorder, and schizophrenia.
|
24787057 |
2014 |
Pervasive Development Disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.
|
25325218 |
2014 |
Autism Spectrum Disorders
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results suggest that PRODH and COMT may interact to contribute to the ASD phenotype in individuals with VCFS.
|
25325218 |
2014 |
Catatonia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Chorea
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Encephalitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Hypoglycemic coma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Lupus Erythematosus, Systemic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Medical conditions associated with catatonia included auto-immune encephalitis (systemic lupus erythematosus [N=3] and anti-NMDA-receptor encephalitis [N=1]), seizures (N=1), ciclosporin encephalitis (N=1), post hypoglycaemic coma encephalitis (N=1), and genetic or metabolic conditions (chorea [N=2], 5HT cerebrospinal fluid deficit [N=1], storage disease [N=1], fatal familial insomnia [FFI; N=1], and PRODH mutations [N=1]).
|
22401837 |
2012 |
Malignant neoplasm of kidney
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we identified the upregulated miR-23b in renal cancer as an important regulator of POX.
|
20562915 |
2010 |
Renal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we identified the upregulated miR-23b in renal cancer as an important regulator of POX.
|
20562915 |
2010 |
Anxiety
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.
|
19232576 |
2009 |
Anxiety Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.
|
19232576 |
2009 |
Autistic Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Individual significance (P = .02 without correction for multiple testing) was reached for the association between autism and a 350-kilobase deletion located at 22q11 and spanning the PRODH and DGCR6 genes.
|
19736351 |
2009 |
Colorectal Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.
|
18794809 |
2008 |
Epilepsy
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
We screened four Italian children with HPI presenting epilepsy, mental retardation, and behavioral disorders for PRODH gene mutations, and attempted a genotype-phenotype correlation.
|
18197084 |
2008 |